Neuropsychobiology · 1999 · 81 citations · 24 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression PharmacotherapyPsychostimulant PharmacologySerotonergic PharmacologyAntidepressant MedicationsAntidepressant ResponseMechanisms Of Antidepressant ActionNatural Killer Cell CytotoxicityPharmacology Of Serotonergic AgentsSelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor UseSerotonin Receptors
Depressed mood has been associated with reduced natural killer cell activity (NKCA). Further, amelioration of depressive symptoms by pharmacotherapy has resulted in augmented NKCA. Serotonin, an indoleamine implicated in the pathophysiology of affective disorders, enhances NKCA in vitro and lymphocytes possess serotonin transporters and receptors. The present study evaluated NKCA in depressed outpatients before and during treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac(R)). Further, the SSRIs, fluoxetine and paroxetine (Paxil(R)), were also incubated in vitro with lymphoid cells to evaluate possible direct effects of SSRIs on NKCA. Depressed outpatients were administered fluoxetine (20 mg/day) for 4 weeks. NKCA and severity of depression were evaluated at weeks 0, 1, 2, and 4. Serum concentrations of fluoxetine and norfluoxetine were obtained as well. Mononuclear cells obtained from nonpatient volunteers were incubated with pharmacologic concentrations of fluoxetine or paroxetine and NKCA measured with a standard chromium release assay. Fluoxetine treatment resulted in decreased symptoms of depression and increased serum concentrations of fluoxetine and norfluoxetine. Further, fluoxetine treatment was associated with augmented NKCA in a subgroup of depressed outpatients exhibiting low NKCA at baseline. Fluoxetine had no effect on NKCA in depressed individuals exhibiting high NKCA at baseline. Incubation of mononuclear cells with fluoxetine and paroxetine augmented NKCA in vitro. The enhancing effects of antidepressants on NKCA in vivo and in vitro indicate a possible direct drug interaction with lymphoid cells during pharmacotherapy, suggesting that pharmacologic treatment of depression may result in enhanced immune competence as indexed by enhanced NKCA and that NKCA could be pharmacologically augmented with antidepressants in individuals with compromised immune function.
24
M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.6K citations · Full text
Natural Killer Cells: Characteristics and Regulation of Activity
Ronald B. Herberman, Julie Y. Djeu, H. David Kay et al. · Immunological Reviews · 1979 · 576 citations
Reduction of immune function in life stress and depression
Michael R. Irwin, Tom W. Patterson, Tom L. Smith et al. · Biological Psychiatry · 1990 · 346 citations
Psychological Depression and 17-Year Risk of Death from Cancer1
Richard B. Shekelle, William J. Raynor, Adrian M. Ostfeld et al. · Psychosomatic Medicine · 1981 · 322 citations
Medicine, Oncology, Psychology +11